Overview

Melatonin and Osteogenic Loading on Osteopenia

Status:
Recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
This study will be assessing the efficacy of melatonin and/or osteogenic loading on modulating bone health in an osteopenic population.
Phase:
Early Phase 1
Details
Lead Sponsor:
Duquesne University
Collaborator:
OsteoStrong
Treatments:
Melatonin